Scientists report in Nature using pluripotent stem cells to generate human stomach tissues in a petri dish that produce acid and digestive enzymes. Publishing their findings online Jan. 4, researchers ...
A new $3.2 million National Institutes of Health (NIH) R01 grant is helping University of Nevada, Reno School of Medicine (UNR Med) researchers delve into one of the body’s most fascinating processes ...
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and is estimated to affect 9.5 million people worldwide. Subscribe to our ...
In a proof of concept that may reshape the treatment landscape for insulin-dependent diabetes, scientists have demonstrated that human stomach cells can be reprogrammed to secrete insulin—potentially ...
Mayo Clinic's Engineering & Therapeutics in Gastrointestinal Disease Lab is implementing microrobotics in the gastrointestinal tract using a swallowable, remote-controlled robotic capsule.
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide. Low insulin levels allow ...
Scientists inch closer to an autologous diabetes cell therapy that dodges the challenge of immune rejection, creating insulin-producing cells from the lining of the gut. As of 2025, an estimated 9.5 ...
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide. Low insulin levels allow ...